AZIYO BIOLOGICS, INC. (AZYO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	8-K	S-1/A
Net sales	49.2	47.4	42.7	42.9
Net sales growth	3.8%	11.0%	-0.5%
Cost of goods sold	30.0	28.4	22.1
Gross profit	19.2	19.0	20.6	19.8
Gross margin	39.1%	40.1%	48.2%	46.1%
Sales and marketing	20.2	18.8	17.6	16.2
General and administrative	16.6	13.7	10.6	9.6
Research and development	8.9	9.3	6.0	2.4
FiberCel litigation costs, net	5.2	0.3
Total operating expenses	51.0	42.1	34.2	28.2
Loss from operations	-31.7	-23.0	-13.6	-8.4
Operating margin	-64.5%	-48.6%	-31.9%	-19.6%
Interest expense	-5.3	-5.3	-5.6
Loss before provision for income taxes	-32.9	-24.8	-21.8
Income tax expense	0.0	0.1	0.0	0.0
Net loss	-32.9	-24.8	-21.8	-11.9

Net loss per share - basic (in dollar per share)	($2.38)	($2.38)	($8.88)	($18.48)
Net loss per share - diluted (in dollar per share)	($2.38)	($2.38)	($8.88)	($18.48)

Weighted average common shares outstanding - basic	13.8	10.4	2.9	0.0
Weighted average common shares outstanding - diluted	13.8	10.4	2.9